THOC4 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the THOC4 protein, a key component of the THO complex involved in mRNA processing and export from the nucleus to the cytoplasm. THOC4 plays a crucial role in the regulation of gene expression and the integrity of the mRNA surveillance system. These inhibitors function primarily by binding to critical regions of the THOC4 protein, such as its RNA-binding domains or sites essential for interacting with other components of the THO complex. By occupying these key binding sites, THOC4 inhibitors effectively disrupt the protein's ability to facilitate the transport of mRNA, leading to alterations in gene expression profiles. Additionally, some THOC4 inhibitors may exert their effects through allosteric mechanisms, whereby they bind to sites away from the active regions and induce conformational changes that impair the protein's functionality. The binding interactions between THOC4 inhibitors and the protein are typically stabilized by a variety of non-covalent forces, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions, ensuring effective inhibition.
Structurally, THOC4 inhibitors exhibit considerable diversity, allowing them to engage specifically with the THOC4 protein. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate strong interactions through hydrogen bonding and ionic interactions with key amino acid residues in the protein's binding pockets. Many THOC4 inhibitors also feature aromatic rings or heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein, contributing to the overall stability of the inhibitor-protein complex. The physicochemical properties of THOC4 inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure effective binding and stability in various biological environments. By balancing hydrophilic and hydrophobic regions, THOC4 inhibitors can interact with both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of THOC4 activity across diverse cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin, an anthracycline antibiotic, intercalates into DNA, consequently disrupting the transcriptional machinery and could lead to the downregulation of THOC4 expression by hindering the transcription initiation or elongation process. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
As a transcriptional inhibitor, Actinomycin D binds tightly to DNA sequences at the transcription initiation complex and blocks the elongation phase of RNA synthesis, which could result in reduced transcription of the THOC4 gene. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This toxin inhibits RNA polymerase II, which is essential for mRNA synthesis including THOC4 mRNA, by binding to the enzyme and preventing the elongation of RNA strands, leading to decreased levels of THOC4 transcripts. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide, a diterpene triepoxide, inhibits the transcription of a broad range of genes by affecting the activity of RNA polymerase II, which is likely to suppress THOC4 gene expression as part of a global transcriptional downregulation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
As a topoisomerase I inhibitor, Camptothecin creates stable DNA-topoisomerase I complexes during transcription, leading to DNA damage and potentially the inhibition of THOC4 expression due to transcription stalling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure, leading to the enhancement of gene transcription in some cases, but could also lead to the repression of specific genes like THOC4 by changing the transcriptional landscape. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA and RNA, inhibits DNA methyltransferases, and could lead to the demethylation and reactivation of silenced genes, but it might also reduce THOC4 expression through epigenetic remodeling. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine, traditionally used as an antimalarial drug, has DNA and RNA intercalating properties which may interfere with the replication and transcription processes, potentially suppressing THOC4 gene expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide has been reported to selectively inhibit translation initiation, which could globally decrease protein synthesis, thereby reducing the synthesis of proteins like THOC4. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide disrupts eukaryotic protein synthesis at the translocation step during translation on ribosomes, which can result in the rapid decrease of THOC4 protein levels, despite not directly influencing mRNA levels. | ||||||